期刊文献+

慢性肾功能不全患者心脏瓣膜钙化相关因素的分析 被引量:5

Analysis of relative factors of heart valve calcification in chronic renal dysfunction patients
下载PDF
导出
摘要 目的:分析慢性肾功能不全,导致心脏瓣膜钙化的相关因素。方法:以50例慢性肾功能不全患者为研究组,50例健康体检者作为对照组,行彩色超声心动图及相关血生化指标检查,分析心脏瓣膜钙化的相关因素。结果:1.研究组患者心脏瓣膜钙化发生率明显高于对照组(P<0.01),发生钙化的年龄明显低于对照组(P<0.05);2.研究组心脏瓣膜钙化患者的年龄、钙磷乘积(Ca×P)、C-反应蛋白(CRP)明显高于对照组患者,前白蛋白、总蛋白、白蛋白明显低于对照组患者。结论:慢性肾功能不全患者,因疾病消耗、血液透析、营养不良、炎症、动脉粥样硬化以及钙磷代谢紊乱等,均使患者心脏瓣膜钙化的发生率明显增加。 Objective:To analyze relative factors contribute to heart valve calcification in chronic renal dysfunction patients.Methods:100 people were divided into experiment group(n =50) with chronic renal dysfunction and control group(n =50) with healthy volunteers.The heart valves were evaluated with echocardiography,and relative biochemical criterion was examed.Results:1.Ratio of heart valve calcification in experiment group was higher than control group(P 0.01).Among the people with heart valve calcification,people in the experiment group are younger than those in control group(P 0.01).2.Age,Ca ×P,CRP level in experiment group was higher,but level of prealbumin,albumin and total protein was lower than the patients in control group.Conclusion:Heart valve calcification is increased in people with chronic renal dysfunction because of hemodialysis,dystrophy,inflammation,atherosclerosis and metabolic disturbance of calcium and phosphor.
作者 刘子罡
出处 《心肺血管病杂志》 CAS 2011年第5期408-410,共3页 Journal of Cardiovascular and Pulmonary Diseases
关键词 慢性肾功能不全 心脏瓣膜钙化 危险因素 Chronic renal dysfunction Heart valve calcification Risk factor
  • 相关文献

参考文献8

  • 1Chen Langxing(陈朗星),Xu Hua(徐华),Li Yijun(李一俊),He Xiwen(何锡文). Chinese J. Anal. Chem.(分析化学),2000,28(2):232-239
  • 2Bakker E,Willer M,Lerchl M. Anal. Chem.,1994,66: 516-521
  • 3Bakker E,Pretsch E. J. Electrochem. Soc.,1997,144(5): L125-127
  • 4Bakker E,Pretsch E. Anal. Chem.,1998,70: 295-302
  • 5戎殳,叶朝阳,牛晓萍,高文武,4梅长林.血液透析患者心脏瓣膜钙化及其危险因素[J].中华肾脏病杂志,2004,20(5):364-366. 被引量:39
  • 6Mi Y M,Bakker E. Anal. Chem.,1999,71: 5279-5287
  • 7赵小仲.老年钙化性心脏瓣膜病临床研究[J].心肺血管病杂志,1999,18(2):127-129. 被引量:7
  • 8Rufino M, Garcia S, J imenez A, et al. Heart valve calcification and calcium X phosphorus product in hemodialysis patients : Anal- ysis of optimum values for its prevention. Kidney Int Suppl,2003, 85:115-118.

二级参考文献16

  • 1任长裕,赵小明.生物瓣膜钙化实验研究进展[J].上海医学,1989,12(9):550-552. 被引量:3
  • 2刘坤申 侯秉森.老年退行性心脏瓣膜病诊治原则与经验[J].实用内科杂志,1992,12(2):68-68.
  • 3R.Harrys 卞志强(译).老年心脏病学[M].北京:人民军医出版社,1989.180.
  • 4Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int, 1999, 55: 1899-1911.
  • 5Wong M, Tei C, Shah PM. Sensitivity and specificity of two-dimensional echocardiography in the detection of valvular calcification. Chest, 1983, 84: 423-427.
  • 6Ribeiro S, Ramos A, Brando A, et al. Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.Nephrol Dial Transplant, 1998, 13: 2037-2040.
  • 7London GM, Pannier B, Marchais F, et al. Calcification of aortic valve in the dialyzed patient. J Am Soc Nephrol, 2000, 11:778-783.
  • 8Zoccali C, Benedetto FA, Mallamaci F, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed investigators. Cardiovascular risk extended evaluation in dialysis patients. J Hypertens, 2000, 18: 1207-1213.
  • 9Yeun JY, Levine RA, Mantadilok V, et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2000, 35: 469-476.
  • 10Adler Y, Vaturi M, Fink N, et al. Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis, 2000,152:451-456.

共引文献45

同被引文献49

  • 1黎磊石,刘志红主编.中国肾脏病学[M].北京:人民军医出版社,2008,1328-1338
  • 2STROZECKI P, ODROWAZ-SYPNIEWSKA G, MANITIUS J. Cadiac valve calcifications and left ventricular hypertrophy in henodialysis patients[J]. Ren Fail,2005,27(6) :733 -738.
  • 3生杰,赵久阳.慢性肾脏病患者钙磷代谢紊乱与心瓣膜钙化[J].中国血液净化,2012,11(2):99-101.
  • 4Wang AY,Ho SSjWang M,et al.Cardiac valvular calicifi- cation as a marker of atherosclerosis and arteral calicification in endstage renal disease[J].Arch Intern Med,2005,165(3):327-332.
  • 5Hruska KA,Mathew S,Lund RJ,et al.The pathogenesis of vascular calcification in the chronic kidney disease min- eral bone disorder:the links between bone and the vascu- lature[J].Semin Nephrol,2009,29(2):S156-S165.
  • 6Leopold JA.Cellular mechanisms of aortic valve calcifica- tion[J].Circ Cardiovasc Interv,2012,5(4):605-614.
  • 7Marks J,Debnam ES,Unwin RJ,et al.Phosphate homeosta- sis and the renal-gastrointestinal axis[J].Am J Physiol Renal Physiol,2010,299(2):F285-F296.
  • 8Gattineni J,Bates C,Twombley K,et al.FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophos- phatemia in vivo predominantly via FGF receptor I[J].Am J Physiol Renal Physiol,2009,297(2):F282-F291.
  • 9Hu MC,Shi M,Zhang J,et al.Klotho:a novel phosphaturic substance acting as an autocrine enzyme in the renal prox- imal tubule[J],FASEB J,2010,24(9):3438-3450.
  • 10Adeney KL,Siscovick DS,Ix JH,et al.Association of serum phosphate with vascular and valvular calcification in mod- erate CKD[J].J Am Soc Nephrol,2009,20(2):381-387.

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部